EV/EBITDA
-2.75
-0.33-13.64%
51 min ago
Summary
- As of March 12, 2025, GLUE EV/EBITDA is -2.75, with a fall of -0.33 (-13.64%) during the most recent trading day.
- Over the past year, GLUE EV/EBITDA has dropped by -1.23 (-80.92%).
- GLUE EV/EBITDA is now -223.53% below its all-time high of -0.85.
Performance
GLUE EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
GLUE EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -13.6% | +13.6% | +10.6% |
| 1 m1 month | -6.6% | +6.9% | +5.5% |
| 3 m3 months | +16.2% | -15.9% | -13.2% |
| 6 m6 months | -16.5% | +7.4% | +10.6% |
| ytdytd | +3.5% | -3.2% | -2.6% |
| 1 y1 year | -80.9% | +60.4% | +17.0% |
| 5 y5 years | - | - | - |
GLUE EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -36.8% | -2.88 | +4.5% | |
| 3 m | 3-month | -2.01 | -36.8% | -3.28 | +16.2% |
| 6 m | 6-month | -1.75 | -57.1% | -4.57 | +39.8% |
| 1 y | 1-year | -1.18 | -133.1% | -4.57 | +39.8% |
| 3 y | 3-year | -0.85 | -223.5% | -6.83 | +59.7% |
| 5 y | 5-year | -0.85 | -223.5% | -34.19 | +92.0% |
| alltime | all time | -0.85 | -223.5% | -34.19 | +92.0% |
Monte Rosa Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -2.75(-3.5%) |
| 2024 | -2.85(+75.9%) |
| Date | Value |
|---|---|
| 2023 | -1.62(-52.1%) |
| 2022 | -3.38(-60.4%) |
| 2021 | -8.54 |
FAQ
- What is Monte Rosa Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Monte Rosa Therapeutics?
- What is GLUE EV/EBITDA year-to-date change?
- What is Monte Rosa Therapeutics EV/EBITDA year-on-year change?
What is Monte Rosa Therapeutics EV/EBITDA?
The current EV/EBITDA of GLUE is -2.75
What is the all time high EV/EBITDA for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high EV/EBITDA is -0.85
What is GLUE EV/EBITDA year-to-date change?
Monte Rosa Therapeutics EV/EBITDA has changed by +0.10 (+3.51%) since the beginning of the year
What is Monte Rosa Therapeutics EV/EBITDA year-on-year change?
Over the past year, GLUE EV/EBITDA has changed by -1.23 (-80.92%)